Dana-Farber Cancer Institute

Back to list

Locations

450 Brookline Ave

Dana 2073

Boston, MA 2215

Phone: (617) 632-5138

Transplant Summary

From January 1, 2022 to December 31st, 2023

Program type: Adult, Pediatric

130

Marrow

556

PBSC

Cord Blood

457

Autologous*

*PBSC or marrow

Overview

Dana-Farber Brigham Cancer Center hematopoietic stem cell transplantation program is an adult oncology effort of Dana-Farber and the Brigham and Women's Hospital. Dana-Farber Cancer Institute and Boston Children's Hospital work together to provide pediatric stem cell transplantation.

This center has been performing allogeneic transplants since 1984 and has been an NMDP transplant center since March 1989.

Attending physicians

Adult - Joseph H. Antin, Phillipe Armand, Corey Cutler, Christopher Gibson, Mahasweta Gooptu, Vincent Ho, Amar Kelkar, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Robert Soiffer
Pediatric - Suneet Agarwal, Francesca Alvarez Calderon, Susanne Baumeister, Christy Duncan, Ulrike Gerdemann, Lev Gorfinkel, Emily Heikamp, Malika Kapadia, Amy Keating, Leslie Lehmann, Miki Nishitani, Susan Prockop, Jared Rowe, Grant Rowe, Takuto Takahashi, Christina Ullrich, Franziska Wachter, Lara Wahlster

Transplants performed

Marrow/PBSC, single cord, and double cord

Cord blood transplants

Adult and pediatric

Other programs and services

Discounted and free housing resources on a need basis.

Patient survival information for this center

Dana-Farber Brigham Cancer Center

This center's actual 1-year survival results are above the expected rate for this center*.

The survival information we have for this center includes ONLY:

Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
Who had their transplant at a U.S. transplant center, and
Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 754 patients.

The actual 1-year survival of these patients is 80.6%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 71.6% and 77.5%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report

at bloodcell.transplant.hrsa.gov.

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

This center's actual 1-year survival results are above the expected rate for this center*.

The survival information we have for this center includes ONLY:

Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
Who had their transplant at a U.S. transplant center, and
Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 164 patients.

The actual 1-year survival of these patients is 91.9%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 80.7% and 90.9%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report

at bloodcell.transplant.hrsa.gov.

* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.

The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.

Total adult transplants

932

Transplants reported by the centers (from January 1, 2022 to December 31, 2023)

	Marrow	PBSC	Cord blood	Total
Allogeneic
Related donor	Marrow 14	PBSC 130	Cord blood 0	Total 144
Unrelated donor	Marrow 27	PBSC 412	Cord blood 0	Total 439
Total allogeneic	Marrow 41	PBSC 542	Cord blood 0	Total 583
Autologous	Marrow Both marrow & PBSC 349	PBSC —	Cord blood —	Total 349
Total combined	Marrow Both marrow & PBSC 932	PBSC —	Cord blood 0	Total 932

Total pediatric transplants

226

Transplants reported by the centers (from January 1, 2022 to December 31, 2023)

	Marrow	PBSC	Cord blood	Total
Allogeneic
Related donor	Marrow 44	PBSC 5	Cord blood 2	Total 51
Unrelated donor	Marrow 45	PBSC 9	Cord blood 13	Total 67
Total allogeneic	Marrow 89	PBSC 14	Cord blood 15	Total 118
Autologous	Marrow Both marrow & PBSC 108	PBSC —	Cord blood —	Total 108
Total combined	Marrow Both marrow & PBSC 211	PBSC —	Cord blood 15	Total 226

All Diseases

Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)

	0-18	19-44	45-64	65+	Total
Related	0-18 46	19-44 56	45-64 58	65+ 35	Total 195
Unrelated	0-18 61	19-44 73	45-64 153	65+ 219	Total 506
Autologous	0-18 102	19-44 86	45-64 176	65+ 93	Total 457
Total	0-18 209	19-44 215	45-64 387	65+ 347	Total 1158

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants can be found:

U.S. Transplant Data by Center (Opens in a new tab)
report at blood cell.transplant.hrsa.gov
List of diseases

Dana-Farber Cancer Inst

450 Brookline Ave

Boston, MA 2215

Phone:877-441-DFCI (441-3324).

For more information about this program: https://www.dana-farber.org/adult-survivorship-program/

Overview

The staff at our adult survivorship clinic can help you manage long-term and late effects of cancer treatment and guide you in living a healthier lifestyle. At your appointment, we will review your medical records, including past cancer diagnosis and treatment, current health status, and general quality of life. We'll provide you with a comprehensive summary of recommendations that can serve as a useful guide to you and your primary care doctor, outlining potential late effects and offering helpful medical information related your past treatment and future care. We offer specialized expertise and services including: Cardiologists who work to treat and prevent heart damage and related problems sometimes associated with cancer treatment; Community resource specialists to help you find survivorship resources near your home, such as advocacy, employment rights, fertility resources, financial support, health insurance, and support groups; Endocrinologists who diagnose and treat issues related to endocrine glands, such as the thyroid, adrenal glands, and pituitary glands; Exercise consultations with an exercise physiologist, to help survivors of any cancer diagnosis experience the benefits of safe, effective, regular physical activity, answer fitness-related questions, and provide personalized exercise tips; Gynecologists to help with fertility issues and sexual health; Lymphologists to diagnose and treat issues related to the immune system in cancer survivors; Nephrologists who work with survivors to diagnose and treat issues related to the kidneys; Nutrition counseling to strengthen healthy eating habits for cancer survivors; Education and support, including classes, support groups, and individual appointments designed to help cancer survivors and their family members address the emotional, mental, social, and spiritual aspects of surviving cancer; Sexual health program to address changes in sexual health during and after cancer treatment

Staff

Program Director:Corey Cutler, MD

Medical Specialties in Program

Cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.

Medical Services Offered

Chronic GVHD management, genetic counseling, nutrition/dietetics, sexual health, social services, vaccinations.

Telemedicine services are available.

Patient Eligibility

Adults

Allogeneic and Autologous transplant recipients
Adults: 12 months after transplant.
Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
Does accept patients who were transplanted at another hospital

Dana-Farber Cancer Institute

Locations

Transplant Summary

Overview

Attending physicians

Transplants performed

Cord blood transplants

Other programs and services

Patient survival information for this center

Dana-Farber Brigham Cancer Center

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Total adult transplants

932

Total pediatric transplants

226

All Diseases

Transplant center resources

NMDP patient navigators

More resources

Dana-Farber Cancer Inst

Overview

Staff

Medical Specialties in Program

Medical Services Offered

Patient Eligibility

Explore

Explore

Connect with us

Connect with us